We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Use of Signal Transduction Inhibitors to Treat Cancer in Children Questioned

By Biotechdaily staff writers
Posted on 24 Mar 2008
A drug that had been found effective for treating medulloblastoma, a type of brain tumor found mostly in children, in a mouse model has now been found to cause permanent bone damage in young mice and may not be appropriate for use in human children.

In 2004 researchers treated mice from a line that had been genetically engineered to develop medulloblastoma with oral doses of HhAntag, a signal transduction inhibitor (STI) known to block the function of a molecule called smoothened (Smo). More...
The suppression of Smo also suppressed several genes that are critical to triggering and driving tumor growth. The compound inhibited cell proliferation and led to the death of tumor cells, resulting in regression of the medulloblastoma. The Smo protein is part of a biochemical cascade of reactions called the Sonic Hedgehog pathway (Shh). The Shh pathway triggers normal growth of the cerebellum in the fetus, but abnormal activity during infancy and early childhood causes medulloblastoma. The hedgehog pathway does not function in tumor cells cultured in dishes: only animal studies were able to show that HhAntag could halt and reverse an otherwise fatal cancer.

In the current study, investigators at The Children's Hospital of Philadelphia (PA, USA) tested HhAntag on young mice, 10 to 14 days old, in contrast to the adult mice tested previously. They reported in the March 2008 issue of the journal Cancer Cell that when examined after only four doses of the drug, the treated mice were found to be smaller with lower weight and shorter bones than untreated mice, and the effects were not reversible.

"We already knew that the same biological pathway involved in the growth of tumors was also involved in bone development,” said senior author Dr. Tom Curran, professor of developmental biology at The Children's Hospital of Philadelphia, "but we did not expect temporary inhibition to cause an irreversible change in bone growth. While it is not clear that the bone defects we observed in mice would also occur in children, and while signal transduction inhibitors may still represent a highly promising approach to treating pediatric cancer, it may be important to perform pre-clinical testing in young animals before moving ahead to clinical trials. Signal transduction inhibitors such as this drug may still prove beneficial in treating children's cancers, but our findings raise questions about possible adverse effects during childhood development.”


Related Links:
The Children's Hospital of Philadelphia

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Hematology Consumables
Bioblood Devices
New
Silver Member
Connectivity Solution
EKF Link
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.